Microvast achieved record annual revenue of $379.8 million in 2024, up 24% year-over-year, with Q4 revenue reaching $113.4 million and a gross margin of 36.6%.
EMEA region drove growth with 123% year-over-year revenue increase to $187.7 million, while APAC revenue declined 19% due to strategic repositioning away from low-margin segments; U.S. revenue rose 360% to $14.4 million.
Gross margin improved significantly to 31.5% for the full year (up from 18.7% in 2023), and adjusted EBITDA was positive at $8.6 million in Q4, reflecting operational efficiencies and cost control.
The company ended 2024 with $109.6 million in cash and cash equivalents, generated positive operating cash flow of $2.8 million, and management no longer sees substantial doubt about its ability to continue as a going concern.
For 2025, Microvast expects revenue growth of 18% to 25% ($450–$475 million), aims to maintain a gross margin target of 30%, and will focus on capacity expansion, innovation, and strategic partnerships to drive further growth and profitability.